Raymond James Financial Inc Eye Point Pharmaceuticals, Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 10,148 shares of EYPT stock, worth $67,179. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,148Holding current value
$67,179% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EYPT
# of Institutions
154Shares Held
58.3MCall Options Held
177KPut Options Held
263K-
Cormorant Asset Management, LP Boston, MA8.33MShares$55.1 Million4.66% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.18MShares$34.3 Million1.63% of portfolio
-
Franklin Resources Inc San Mateo, CA4.01MShares$26.6 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.79MShares$25.1 Million0.06% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$24.9 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $226M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...